Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY23.20 CNY
Change Today +0.20 / 0.87%
Volume 4.2M
000989 On Other Exchanges
As of 1:14 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

jiuzhitang co ltd-a (000989) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/12/15 - CNY48.15
52 Week Low
08/28/14 - CNY13.48
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for JIUZHITANG CO LTD-A (000989)

Related News

No related news articles were found.

jiuzhitang co ltd-a (000989) Related Businessweek News

No Related Businessweek News Found

jiuzhitang co ltd-a (000989) Details

Jiuzhitang Co., Ltd. produces and sells traditional Chinese medicines in China. The company offers condensed pills, health food, herbal extracts, and tablets. Its products also include donkey-hide gelatin blood tonic and yiganning granules, Jianweiyuyang Pian, Ganlike, Piantanling, Yilingjing, and Siqikang. The company also exports its products to Europe, the United States, Japan, and Southeast Asia. Jiuzhitang Co., Ltd. is based in Changsha, China.

jiuzhitang co ltd-a (000989) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiuzhitang co ltd-a (000989) Key Developments

Jiuzhitang Co., Ltd. to Report First Half, 2015 Results on Jul 30, 2015

Jiuzhitang Co., Ltd. announced that they will report first half, 2015 results on Jul 30, 2015

Jiuzhitang Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 15, 2015

Jiuzhitang Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 15, 2015., at 14:30 China Standard Time. Agenda: To consider eligibility for listed company's assets purchase via share offering; to consider the assets purchase constitutes connected transaction; to consider the scheme for the connected transaction regarding assets purchase; to sign conditional agreement on the assets purchase; to consider profit compensation agreement; to consider connected transaction regarding assets purchase; to consider the audit report of major assets restructuring ; to consider the statement on compliance and completeness of implementing the legal proceedings of the major assets restructuring and the effectiveness of the legal document submitted; to consider compliance with the 4th and 13th article in the Provisions on Several Issues Concerning the Regulation of Major Assets Restructuring; to consider exemption of Li Zhenguo from the tender offer obligation; and to consider authorization to the board to handle matters in relation to the asset purchase via share offering.

Jiuzhitang Co., Ltd. to Report Q1, 2015 Results on Apr 24, 2015

Jiuzhitang Co., Ltd. announced that they will report Q1, 2015 results on Apr 24, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000989:CH CNY23.20 CNY +0.20

000989 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000989.
View Industry Companies

Industry Analysis


Industry Average

Valuation 000989 Industry Range
Price/Earnings 24.5x
Price/Sales 4.2x
Price/Book 3.7x
Price/Cash Flow 24.9x
TEV/Sales 3.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIUZHITANG CO LTD-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at